Courses List

0
No products in the cart.
← Literature Database

Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents.

Practice Point

Bader Alsaikhan, Sero Andonian

Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2011 · Vol. 5 · Issue 1 · 53-7

PMID: 21470517 DOI: 10.5489/cuaj.09140

Academy Summary

Alsaikhan and Andonian reviewed the available literature on shock wave lithotripsy in patients requiring anticoagulation or antiplatelet therapy, with particular attention to the competing risks of renal bleeding and cardiovascular or thromboembolic complications.

The authors searched MEDLINE for literature published between 1987 and 2010 using terms related to lithotripsy, anticoagulants, aspirin, platelet inhibitors, haematoma, and drug-eluting coronary stents. A total of 58 articles were reviewed, although the available evidence was generally weak and no randomized controlled trials specifically evaluating SWL in anticoagulated patients were identified. (pmc.ncbi.nlm.nih.gov)

The review emphasized that SWL should be considered a high-bleeding-risk procedure because renal or perirenal haemorrhage can occur within a relatively confined anatomical space.

At the same time, stopping antiplatelet therapy may expose certain patients, particularly those with recent myocardial infarction or coronary stents, to serious complications such as stent thrombosis, myocardial infarction, or death.

The authors therefore recommended stratifying patients according to cardiovascular and thrombotic risk rather than applying a single medication rule to everyone.

In lower-risk patients, temporary interruption of antiplatelet therapy was considered reasonable after consultation with the prescribing cardiologist. In intermediate- and high-risk cardiovascular patients, elective SWL was generally considered better postponed.

The review also highlighted that heparin is not a true substitute for antiplatelet therapy, because anticoagulants and antiplatelet agents act through different mechanisms and heparin does not protect against platelet-mediated coronary stent thrombosis. (pmc.ncbi.nlm.nih.gov)

When stone treatment could not safely be postponed and antithrombotic treatment could not be interrupted, ureteroscopy with laser lithotripsy was presented as the safer alternative.

Unlock the Academy Interpretation for Free

Create a free Lithotripsy Academy account or log in to access the complete Academy interpretation, including Key Findings, Clinical Takeaway, Limitations, and Expert Commentary

Subscribe to View Details Already a member? Log in
Comments & Discussion0 comments

Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.

No comments yet. Start the discussion.